Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Centrexion Therapeutics Corporation
CNTX | US
3.06
USD-0.30
-8.93%
CNTX | US
Loading StockChartView...
About Centrexion Therapeutics Corporation
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
16/03/2026
Close
3.06
Open
3.32
High
3.62
Low
3.02
Context Therapeutics Inc. a biopharmaceutical company develops products for the treatment of solid tumors in the United States. It develops CLDN6xCD3 bsAb an anti-CD3 x anti-Claudin 6 antigen bispecific monoclonal antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular Inc. for the development of an anti-claudin 6 bispecific monoclonal antibody for cancer therapy. Context Therapeutics Inc. was incorporated in 2015 and is headquartered in Philadelphia Pennsylvania.
View LessCNTX | US
Risk
93.5
Sharpe
3.88
Luna's Score
49/100
Recommendation
Hold
Luna says (CNTX | US)
What's Working
Positive Momentum
Value Stock (Price to Book < 3)
Strong Sharpe Ratio (> 1.2)
What's not Working
Weakness based on declining price with high volume
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
108.9%1 month
93.5%3 months
93.5%6 months
90.8%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
1.49
Debt to equity
-
Debt to assets
-
Ent. to EBITDA
1.60
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-20.01M
MarketCap
229.49M
MarketCap(USD)
229.49M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-29.68
Short ratio
3.89
Short perc.
1.64
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
1.54
Range1M
1.54
Range3M
2.58
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
1.78
Price X volume
5.40M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 1.60 | 0.53 | Expensive |
| Ent. to Revenue | - | 3,967.00 | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 1.49 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 93.46 | 72.80 | Riskier |
| Debt to Equity | - | -1.23 | - |
| Debt to Assets | - | 0.25 | - |
| Market Cap | 229.49M | 3.66B | Emerging |
